Join fellow NeuroAdvocates in urging Congress to stop the Office of Management and Budget from finalizing a proposed rule that would override expert considerations into research funding decisions, increase the risk of grant cancellations, and restrict scientific communication and collaboration. These changes would be especially harmful to early-career scientists who rely on stable funding to build research careers, slowing scientific progress and weakening U.S. leadership in biomedical research.
